IgA Vasculitis Induced by Ustekinumab During Treatment for Crohn’s Disease: A Case Report
DOI:
https://doi.org/10.2340/actadv.v105.44276Keywords:
IgA Vasculitis, IL-12/23 inhibitor, Crohn's Disease, UstekinumabDownloads
References
Urganci N, Sakar M, Yalcin O, Kalyoncu D. Henoch-Schönlein purpura induced by infliximab for Crohn’s disease: a case report and literature review. Rev Gastroenterol Mex Engl Ed 2022; 87: 110–112. DOI: https://doi.org/10.1016/j.rgmxen.2021.10.005
Li H, Xin Q, Hong L, Hu Y, Lin L, Guo M, et al. Mendelian randomization analysis reveals causality of inflammatory bowel disease on risks of Henoch-Schönlein purpura and immune thrombocytopenia. Dig Liver Dis 2024; 56: 92–97. DOI: https://doi.org/10.1016/j.dld.2023.08.044
Velasquez Ospina LE, Paradakis KA, Urquhart SA. Ustekinumab-induced vasculitis in a patient with Crohn’s disease. ACG Case Rep J 2025; 12: e01625. DOI: https://doi.org/10.14309/crj.0000000000001625
Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu J, et al. Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol 2021; 12: 771619. DOI: https://doi.org/10.3389/fimmu.2021.771619
Yan L, Shen J, Liu L, Yang M, Wang S. IgA vasculitis induced by tumor necrosis factor-α antagonists: clinical features, diagnosis and management. Arch Dermatol Res 2025; 317: 445. DOI: https://doi.org/10.1007/s00403-025-03965-x
Buck M, Dumic I, McDermott W, Nordstrom C, Dawan S, Virata A, et al. Leukocytoclastic vasculitis as a rare dermatologic magnification of Crohn’s disease mimicking cellulitis: a case report. BMC Gastroenterol 2020; 20: 240. DOI: https://doi.org/10.1186/s12876-020-01371-3
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, et al. The real-world effectiveness and safety of ustekinumab in the treatment of Crohn’s disease: results from the SUCCESS Consortium. Am J Gastroenterol 2023; 118: 317–328. DOI: https://doi.org/10.14309/ajg.0000000000002047
Costa-Moreira P, Lopes S, Santos AL, Pedrosa AF, Andrade P, Portugal R, et al. Leukocytoclastic vasculitis related to ustekinumab in a Crohn’s disease patient: first case report and literature review. J Crohns Colitis 2020; 14: 274–276. DOI: https://doi.org/10.1093/ecco-jcc/jjz128
Chugh R, Proctor DD, Little A, Myung P, Cowper S, Imaeda S, et al. Cutaneous vasculitis after ustekinumab induction in Crohn’s disease. Inflamm Bowel Dis 2021; 27: e30–31. DOI: https://doi.org/10.1093/ibd/izaa285
Aykut H, Ordu B, Dertsiz B, Adalı G, Yalçın Ö. Leukocytoclastic vasculitis as a rare adverse effect of ustekinumab in a patient with Crohn’s disease. J Gastrointestin Liver Dis 2025; 34: 137–138. DOI: https://doi.org/10.15403/jgld-6036
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Yu Okada, Yuko Ehara, Kazuo Yashima, Yuichi Yoshida
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
